Kate Haviland

CIK 1663022 · Chief Executive Officer · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

54

Lifetime Open-Market Net

-$13.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCAX Director $21.69 $0 3 2026-06-10
AVLN Director $0 1 2026-05-01
Blueprint Medicines Corp (BPMC) Delisted Chief Executive Officer 0 $129.46 $0 -$13.58M 43 2025-07-21
FULC Director $3.45 $0 7 2025-06-30

Recent Filings · Page 6 of 6

54 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-06-30 Blueprint Medicines Corp (BPMC) Delisted Mixed -$214.4K EDGAR
2017-03-16 Blueprint Medicines Corp (BPMC) Delisted Mixed -$301.7K EDGAR
2017-02-21 Blueprint Medicines Corp (BPMC) Delisted Grant (A) $0 EDGAR
2016-02-02 Blueprint Medicines Corp (BPMC) Delisted Grant (A) $0 EDGAR
Showing 5154 of 54
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.